Literature DB >> 18691283

Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications.

Soko Setoguchi1, Philip S Wang, M Alan Brookhart, Claire F Canning, Liljana Kaci, Sebastian Schneeweiss.   

Abstract

OBJECTIVES: To investigate the potential mechanisms through which conventional antipsychotic medication (APM) might act, the specific causes of death in elderly patients newly started on conventional APM were compared with those of patients taking atypical APM.
DESIGN: Cohort study.
SETTING: Community. PARTICIPANTS: All British Columbia residents aged 65 and older who initiated a conventional or atypical APM between 1996 and 2004. MEASUREMENTS: Cox proportional hazards models were used to compare risks of developing a specific cause of death within 180 days of APM initiation. Potential confounders were adjusted for using traditional multivariable, propensity-score, and instrumental-variable adjustments.
RESULTS: The study cohort included 12,882 initiators of conventional APM and 24,359 initiators of atypical APM. Of 3,821 total deaths within the first 180 day of use, cardiovascular (CV) deaths accounted for 49% of deaths. Initiators of conventional APM had a significantly higher adjusted risk of all CV death (hazard ratio (HR)=1.23, 95% confidence interval (CI)=1.10-1.36) and out-of-hospital CV death (HR=1.36, 95% CI=1.19-1.56) than initiators of atypical APM. Initiators of conventional APM also had a higher risk of death due to respiratory diseases, nervous system diseases, and other causes.
CONCLUSION: These data suggest that greater risk of CV deaths might explain approximately half of the excess mortality in initiators of conventional APM. The risk of death due to respiratory causes was also significantly higher in conventional APM use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691283     DOI: 10.1111/j.1532-5415.2008.01839.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  30 in total

1.  Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States.

Authors:  Charles E Leonard; Cristin P Freeman; Craig W Newcomb; Warren B Bilker; Stephen E Kimmel; Brian L Strom; Sean Hennessy
Journal:  J Clin Exp Cardiolog       Date:  2013

Review 2.  When and how to use instrumental variables in palliative care research.

Authors:  Joan D Penrod; Nathan E Goldstein; Partha Deb
Journal:  J Palliat Med       Date:  2009-05       Impact factor: 2.947

Review 3.  Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.

Authors:  Gianluca Trifiró; Janet Sultana; Edoardo Spina
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

4.  Sedative load and mortality among residents of long-term care facilities: a prospective cohort study.

Authors:  Heidi T Taipale; J Simon Bell; Helena Soini; Kaisu H Pitkälä
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 5.  Identification and management of in-hospital drug-induced delirium in older patients.

Authors:  Angela G Catic
Journal:  Drugs Aging       Date:  2011-09-01       Impact factor: 3.923

6.  Mediators of First- Versus Second-generation Antipsychotic-related Mortality in Older Adults.

Authors:  John W Jackson; Tyler J VanderWeele; Deborah Blacker; Sebastian Schneeweiss
Journal:  Epidemiology       Date:  2015-09       Impact factor: 4.822

7.  Adverse Events Associated with Antipsychotic Use in Hospitalized Older Adults After Cardiac Surgery.

Authors:  Dae H Kim; Krista F Huybrechts; Elisabetta Patorno; Edward R Marcantonio; Yoonyoung Park; Raisa Levin; Abdurrahman Abdurrob; Brian T Bateman
Journal:  J Am Geriatr Soc       Date:  2017-02-10       Impact factor: 5.562

8.  The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults.

Authors:  Amanda R Patrick; William H Shrank; Robert J Glynn; Daniel H Solomon; Colin R Dormuth; Jerry Avorn; Suzanne M Cadarette; Helen Mogun; M Alan Brookhart
Journal:  Value Health       Date:  2011-04-22       Impact factor: 5.725

Review 9.  A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force.

Authors:  Martha Sajatovic; Sergio A Strejilevich; Ariel G Gildengers; Annemiek Dols; Rayan K Al Jurdi; Brent P Forester; Lars Vedel Kessing; John Beyer; Facundo Manes; Soham Rej; Adriane R Rosa; Sigfried Ntm Schouws; Shang-Ying Tsai; Robert C Young; Kenneth I Shulman
Journal:  Bipolar Disord       Date:  2015-09-19       Impact factor: 6.744

10.  Pharmacotherapeutic management of dementia across settings of care.

Authors:  Gail B Rattinger; Mehmet Burcu; Sarah K Dutcher; Pankdeep T Chhabra; Paul B Rosenberg; Linda Simoni-Wastila; Christine S Franey; Loreen D Walker; Ilene H Zuckerman
Journal:  J Am Geriatr Soc       Date:  2013-04-16       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.